Ratio de rentabilidad sobre el patrimonio neto de los accionistas (ROE)
desde 2005
Cálculo
Biogen Inc., ROE, tendencias a largo plazo, cálculo
| ROE | = | 100 | × | Ingresos netos atribuibles a Biogen Inc.1 | ÷ | Total del capital social de Biogen Inc.1 | |
|---|---|---|---|---|---|---|---|
| 31 dic. 2019 | 44.13% | = | 100 | × | 5,888,500 | ÷ | 13,343,200 |
| 31 dic. 2018 | 33.98% | = | 100 | × | 4,430,700 | ÷ | 13,039,600 |
| 31 dic. 2017 | 20.13% | = | 100 | × | 2,539,100 | ÷ | 12,612,800 |
| 31 dic. 2016 | 30.50% | = | 100 | × | 3,702,800 | ÷ | 12,140,100 |
| 31 dic. 2015 | 37.84% | = | 100 | × | 3,547,000 | ÷ | 9,372,800 |
| 31 dic. 2014 | 27.15% | = | 100 | × | 2,934,784 | ÷ | 10,809,010 |
| 31 dic. 2013 | 21.60% | = | 100 | × | 1,862,341 | ÷ | 8,620,242 |
| 31 dic. 2012 | 19.82% | = | 100 | × | 1,380,033 | ÷ | 6,961,523 |
| 31 dic. 2011 | 19.21% | = | 100 | × | 1,234,428 | ÷ | 6,425,499 |
| 31 dic. 2010 | 18.63% | = | 100 | × | 1,005,273 | ÷ | 5,396,506 |
| 31 dic. 2009 | 15.59% | = | 100 | × | 970,132 | ÷ | 6,221,530 |
| 31 dic. 2008 | 13.49% | = | 100 | × | 783,167 | ÷ | 5,806,083 |
| 31 dic. 2007 | 11.53% | = | 100 | × | 638,172 | ÷ | 5,534,295 |
| 31 dic. 2006 | 3.04% | = | 100 | × | 217,511 | ÷ | 7,149,778 |
| 31 dic. 2005 | 2.33% | = | 100 | × | 160,711 | ÷ | 6,905,876 |
Basado en informes: 10-K (fecha de reporte: 2019-12-31), 10-K (fecha de reporte: 2018-12-31), 10-K (fecha de reporte: 2017-12-31), 10-K (fecha de reporte: 2016-12-31), 10-K (fecha de reporte: 2015-12-31), 10-K (fecha de reporte: 2014-12-31), 10-K (fecha de reporte: 2013-12-31), 10-K (fecha de reporte: 2012-12-31), 10-K (fecha de reporte: 2011-12-31), 10-K (fecha de reporte: 2010-12-31), 10-K (fecha de reporte: 2009-12-31), 10-K (fecha de reporte: 2008-12-31), 10-K (fecha de reporte: 2007-12-31), 10-K (fecha de reporte: 2006-12-31), 10-K (fecha de reporte: 2005-12-31).
1 US$ en miles
Comparación con los competidores
Biogen Inc., ROE, tendencias a largo plazo, comparación con la competencia
| Biogen Inc. | AbbVie Inc. | Amgen Inc. | Eli Lilly & Co. | Gilead Sciences Inc. | Johnson & Johnson | Merck & Co. Inc. | Moderna Inc. | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | Thermo Fisher Scientific Inc. | Zoetis Inc. | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 31 dic. 2019 | 44.13% | — | 81.07% | 319.09% | 23.91% | 25.42% | 37.99% | -43.75% | 25.77% | 19.08% | 12.45% | 55.39% |
| 31 dic. 2018 | 33.98% | — | 67.15% | 32.88% | 25.51% | 25.60% | 23.30% | -25.14% | 17.59% | 27.91% | 10.65% | 65.35% |
| 31 dic. 2017 | 20.13% | 104.16% | 7.84% | -1.76% | 22.64% | 2.16% | 6.97% | — | 29.47% | 19.51% | 8.76% | 48.81% |
| 31 dic. 2016 | 30.50% | 128.41% | 25.85% | 19.54% | 71.48% | 23.49% | 9.78% | — | 12.12% | 20.13% | 9.39% | 55.21% |
| 31 dic. 2015 | 37.84% | 130.39% | 24.71% | 16.53% | 97.70% | 21.66% | 9.94% | — | 10.75% | 17.40% | 9.25% | 31.74% |
| 31 dic. 2014 | 27.15% | 101.84% | 20.01% | 15.55% | 78.45% | 23.40% | 24.50% | — | 12.81% | 13.69% | 9.22% | 44.47% |
| 31 dic. 2013 | 21.60% | 91.90% | 23.00% | 26.57% | 27.05% | 18.68% | 8.85% | — | 28.83% | 21.74% | 7.55% | 53.62% |
| 31 dic. 2012 | 19.82% | 156.85% | 22.80% | 27.69% | 27.84% | 16.74% | 11.63% | — | 17.93% | 60.24% | 7.62% | 10.83% |
| 31 dic. 2011 | 19.21% | — | 19.35% | 32.11% | 41.60% | 16.94% | 11.50% | — | 12.18% | -45.65% | 8.84% | — |
| 31 dic. 2010 | 18.63% | — | 19.32% | 40.82% | 49.48% | 23.57% | 1.58% | — | 9.40% | -19.79% | 6.74% | — |
| 31 dic. 2009 | 15.59% | — | 20.32% | 45.45% | 41.40% | 24.25% | 21.85% | — | 9.59% | -17.10% | 5.51% | — |
| 31 dic. 2008 | 13.49% | — | 20.58% | -30.76% | 48.43% | 30.46% | 41.63% | — | 14.08% | -19.75% | 6.66% | — |
| 31 dic. 2007 | 11.53% | — | 17.72% | 21.61% | 46.69% | 24.41% | 18.01% | — | 12.53% | -22.94% | 5.25% | — |
| 31 dic. 2006 | 3.04% | — | 15.56% | 24.25% | -65.54% | 28.11% | 25.25% | — | 27.10% | -47.24% | 1.21% | — |
| 31 dic. 2005 | 2.33% | — | 17.96% | 18.34% | 26.88% | 27.49% | 25.85% | — | 12.32% | -83.72% | 7.99% | — |
Basado en informes: 10-K (fecha de reporte: 2019-12-31), 10-K (fecha de reporte: 2018-12-31), 10-K (fecha de reporte: 2017-12-31), 10-K (fecha de reporte: 2016-12-31), 10-K (fecha de reporte: 2015-12-31), 10-K (fecha de reporte: 2014-12-31), 10-K (fecha de reporte: 2013-12-31), 10-K (fecha de reporte: 2012-12-31), 10-K (fecha de reporte: 2011-12-31), 10-K (fecha de reporte: 2010-12-31), 10-K (fecha de reporte: 2009-12-31), 10-K (fecha de reporte: 2008-12-31), 10-K (fecha de reporte: 2007-12-31), 10-K (fecha de reporte: 2006-12-31), 10-K (fecha de reporte: 2005-12-31).
Comparación con el sector industrial: Productos farmacéuticos, biotecnología y ciencias de la vida
Biogen Inc., ROE, tendencias a largo plazo, comparación con el sector industrial: productos farmacéuticos, biotecnología y ciencias de la vida
| Biogen Inc. | Productos farmacéuticos, biotecnología y ciencias de la vida | |
|---|---|---|
| 31 dic. 2019 | 44.13% | 35.24% |
| 31 dic. 2018 | 33.98% | 27.47% |
| 31 dic. 2017 | 20.13% | 15.62% |
| 31 dic. 2016 | 30.50% | 23.15% |
| 31 dic. 2015 | 37.84% | 22.95% |
| 31 dic. 2014 | 27.15% | 22.62% |
| 31 dic. 2013 | 21.60% | 21.57% |
| 31 dic. 2012 | 19.82% | 18.87% |
| 31 dic. 2011 | 19.21% | 15.24% |
| 31 dic. 2010 | 18.63% | 14.01% |
| 31 dic. 2009 | 15.59% | 18.17% |
| 31 dic. 2008 | 13.49% | 20.50% |
| 31 dic. 2007 | 11.53% | 17.22% |
| 31 dic. 2006 | 3.04% | 22.58% |
| 31 dic. 2005 | 2.33% | 18.74% |
Basado en informes: 10-K (fecha de reporte: 2019-12-31), 10-K (fecha de reporte: 2018-12-31), 10-K (fecha de reporte: 2017-12-31), 10-K (fecha de reporte: 2016-12-31), 10-K (fecha de reporte: 2015-12-31), 10-K (fecha de reporte: 2014-12-31), 10-K (fecha de reporte: 2013-12-31), 10-K (fecha de reporte: 2012-12-31), 10-K (fecha de reporte: 2011-12-31), 10-K (fecha de reporte: 2010-12-31), 10-K (fecha de reporte: 2009-12-31), 10-K (fecha de reporte: 2008-12-31), 10-K (fecha de reporte: 2007-12-31), 10-K (fecha de reporte: 2006-12-31), 10-K (fecha de reporte: 2005-12-31).
Comparación con la industria: Cuidado de la salud
Biogen Inc., ROE, tendencias a largo plazo, comparación con la industria: cuidado de la salud
| Biogen Inc. | Cuidado de la salud | |
|---|---|---|
| 31 dic. 2019 | 44.13% | 22.46% |
| 31 dic. 2018 | 33.98% | 19.68% |
| 31 dic. 2017 | 20.13% | 14.74% |
| 31 dic. 2016 | 30.50% | 19.25% |
| 31 dic. 2015 | 37.84% | 19.06% |
| 31 dic. 2014 | 27.15% | 19.37% |
| 31 dic. 2013 | 21.60% | 19.00% |
| 31 dic. 2012 | 19.82% | 18.22% |
| 31 dic. 2011 | 19.21% | 16.24% |
| 31 dic. 2010 | 18.63% | 14.58% |
| 31 dic. 2009 | 15.59% | 19.44% |
| 31 dic. 2008 | 13.49% | 19.21% |
| 31 dic. 2007 | 11.53% | 17.06% |
| 31 dic. 2006 | 3.04% | 20.33% |
| 31 dic. 2005 | 2.33% | 18.29% |
Basado en informes: 10-K (fecha de reporte: 2019-12-31), 10-K (fecha de reporte: 2018-12-31), 10-K (fecha de reporte: 2017-12-31), 10-K (fecha de reporte: 2016-12-31), 10-K (fecha de reporte: 2015-12-31), 10-K (fecha de reporte: 2014-12-31), 10-K (fecha de reporte: 2013-12-31), 10-K (fecha de reporte: 2012-12-31), 10-K (fecha de reporte: 2011-12-31), 10-K (fecha de reporte: 2010-12-31), 10-K (fecha de reporte: 2009-12-31), 10-K (fecha de reporte: 2008-12-31), 10-K (fecha de reporte: 2007-12-31), 10-K (fecha de reporte: 2006-12-31), 10-K (fecha de reporte: 2005-12-31).